Literature DB >> 26358393

Emerging cytokine networks in colorectal cancer.

Nathan R West1,2, Sarah McCuaig1,2, Fanny Franchini1,2, Fiona Powrie1,2.   

Abstract

Cytokine networks are crucial aspects of tumour immunology, particularly for colorectal cancer (CRC), in which inflammation and antitumour immunity are key determinants of disease progression. In this Review, we highlight new insights into the functions of well-known cytokines in CRC, describe recently discovered roles for a growing number of novel players, and emphasize the complexity and therapeutic implications of the cytokine milieu. We also discuss how cancer mutations and epigenetic adaptations influence the oncogenic potential of cytokines, a relatively unexplored area that could yield crucial insights into tumour immunology and facilitate the effective application of cytokine-modulatory therapies for CRC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26358393     DOI: 10.1038/nri3896

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  164 in total

1.  Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Authors:  Dominik Jauch; Maria Martin; Gabriela Schiechl; Rebecca Kesselring; Hans Jürgen Schlitt; Edward K Geissler; Stefan Fichtner-Feigl
Journal:  Gut       Date:  2011-09-23       Impact factor: 23.059

2.  Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts.

Authors:  Xiaolei Zhang; Peibin Yue; Brent D G Page; Tianshu Li; Wei Zhao; Andrew T Namanja; David Paladino; Jihe Zhao; Yuan Chen; Patrick T Gunning; James Turkson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-23       Impact factor: 11.205

3.  Microbiota organization is a distinct feature of proximal colorectal cancers.

Authors:  Christine M Dejea; Elizabeth C Wick; Elizabeth M Hechenbleikner; James R White; Jessica L Mark Welch; Blair J Rossetti; Scott N Peterson; Erik C Snesrud; Gary G Borisy; Mark Lazarev; Ellen Stein; Jamuna Vadivelu; April C Roslani; Ausuma A Malik; Jane W Wanyiri; Khean L Goh; Iyadorai Thevambiga; Kai Fu; Fengyi Wan; Nicolas Llosa; Franck Housseau; Katharine Romans; XinQun Wu; Florencia M McAllister; Shaoguang Wu; Bert Vogelstein; Kenneth W Kinzler; Drew M Pardoll; Cynthia L Sears
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

4.  Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer.

Authors:  Nichole R Blatner; Mary F Mulcahy; Kristen L Dennis; Denise Scholtens; David J Bentrem; Joseph D Phillips; Soo Ham; Barry P Sandall; Mohammad W Khan; David M Mahvi; Amy L Halverson; Steven J Stryker; Anne-Marie Boller; Ashima Singal; Rebekka K Sneed; Bara Sarraj; Mohammed Javeed Ansari; Martin Oft; Yoichiro Iwakura; Liang Zhou; Andreas Bonertz; Philipp Beckhove; Fotini Gounari; Khashayarsha Khazaie
Journal:  Sci Transl Med       Date:  2012-12-12       Impact factor: 17.956

5.  Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis.

Authors:  Y Wang; K Wang; G-C Han; R-X Wang; H Xiao; C-M Hou; R-F Guo; Y Dou; B-F Shen; Y Li; G-J Chen
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

6.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.

Authors:  Guanglin Cui; Aping Yuan; Rasmus Goll; Jon Florholmen
Journal:  Scand J Gastroenterol       Date:  2012-09-19       Impact factor: 2.423

8.  Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.

Authors:  Yoshiro Itatani; Kenji Kawada; Teruaki Fujishita; Fumihiko Kakizaki; Hideyo Hirai; Takuya Matsumoto; Masayoshi Iwamoto; Susumu Inamoto; Etsuro Hatano; Suguru Hasegawa; Taira Maekawa; Shinji Uemoto; Yoshiharu Sakai; Makoto Mark Taketo
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

9.  Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.

Authors:  G Lurje; W Zhang; A M Schultheis; D Yang; S Groshen; A E Hendifar; H Husain; M A Gordon; F Nagashima; H M Chang; H-J Lenz
Journal:  Ann Oncol       Date:  2008-06-11       Impact factor: 32.976

10.  c-Src drives intestinal regeneration and transformation.

Authors:  Julia B Cordero; Rachel A Ridgway; Nicola Valeri; Colin Nixon; Margaret C Frame; William J Muller; Marcos Vidal; Owen J Sansom
Journal:  EMBO J       Date:  2014-04-30       Impact factor: 11.598

View more
  149 in total

1.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

2.  Development and validation of an immune-related gene pairs signature in colorectal cancer.

Authors:  Jianping Wu; Ying Zhao; Juanwen Zhang; Qianxia Wu; Weilin Wang
Journal:  Oncoimmunology       Date:  2019-04-15       Impact factor: 8.110

3.  UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer.

Authors:  Jun Yin; Wei Luo; Xiang Zeng; Lisi Zeng; Zhiyang Li; Xiaofang Deng; Xiaojun Tan; Weimin Hu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

4.  Rheumatoid arthritis: Modelling cytokine signalling networks.

Authors:  Daehee Hwang; Wan-Uk Kim
Journal:  Nat Rev Rheumatol       Date:  2016-12-01       Impact factor: 20.543

Review 5.  JAK/STAT signaling in stem cells and regeneration: from Drosophila to vertebrates.

Authors:  Salvador C Herrera; Erika A Bach
Journal:  Development       Date:  2019-01-29       Impact factor: 6.868

Review 6.  Basics to advances in nanotherapy of colorectal cancer.

Authors:  Ankita Tiwari; Shivani Saraf; Ankit Jain; Pritish K Panda; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 7.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

Review 8.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

9.  The Itch to degrade ROR-γt.

Authors:  Sascha Rutz; Wenjun Ouyang
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

Review 10.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.